Scientific programme


  AUDITORY MEETING ROOM 1 MEETING ROOM 2 MEETING ROOM 3
10:30-11:45  

DERMOSCOPY
COURSE I

 

G. Argenziano

S. Puig

P. Soyer

   
11:45-13:00  

DERMOSCOPY
COURSE II

 

H. Kittler

A. Lallas

P. Soyer

   
13:30-14:30

SIMPOSIUM 1

Controversies & new development in melanoma

Chairs: C. Garbe - J. Malvehy

 

Will the computers replace the dermatologist?

Yes: J.Malvehy; No: S. Puig

Is the pathology the right gold standard for melanoma?

Yes: L. Requena; No: P. Soyer

Is the new AJCC a progress?

Yes: J. E.Gershenwald; No: J.J. Grob

 

 

 

 

   
14:30-15:30

SIMPOSIUM 2

Controversies & open questions in melanoma

Chairs: V. Sondak - J. Thompson

 

We have biomarkers for treatment decisions

Yes: O. Michielin; No: C. Blank

Do we still need surgery in advanced melanoma?

Yes: J. Thompson; No: J. Larkin

Do we still need target therapy in the age of immunotherapy?

Yes: D. Schadendorf; No: A. Ribas  

     
15:30-16:00 Coffee break - visit to the Exhibition & e-posters viewing
16:00-17:00

INDUSTRY SATELLITE SYMPOSIUM

SANOFI GENZYME + REGENERON

     
17:00-17:15 OPENING CEREMONY      
17:15-17:45

OPENING KEYNOTE LECTURE

Chairs: H. Pehamberger  - J. Thompson

 

Future Developments in melanoma treatment

A. Ribas

     
17:45-19:00 WELCOME RECEPTION      
  AUDITORY MEETING ROOM 1 MEETING ROOM 2 MEETING ROOM 3
08:00-09:00

SYMPOSIUM 3

Epidemiology of melanoma

Chairs: S. Gandini - J. J. Grob - D. Whiteman

 

The worldwide burden of skin cancer

S.Gandini
 

What should be told the public about prevention?

J. J. Grob
 

Melanoma incidence:  signs for a decline?

D. Whiteman
 

Melanoma: differences and trends in Europe

A. M. Forsea

BREAKOUT SESSION 1

Skin cancer guidelines: International structure & cooperation

Chairs: C. Garbe - J. Thompson

BREAKOUT SESSION 2
Building & EADO registry

Chairs: U. Leiter-Stöppke -

M. Weichenthal

 
09:00:10:00

SYMPOSIUM 4

Actinic keratosis

Chairs: K. Peris - A. Stratigos

 

Epidemiology and biology of actinic keratoses

A. Stratigos

 

Classification and grading of actinic keratoses

G. Pellacani

 

Topical treatment of actinic keratoses and field cancerization 

K. Peris

 

New developments in the photodynamic therapy of actinic keratoses

R. M. Szeimies

 

SYMPOSIUM 5

Genetics of melanoma

Chairs: E. Nagore - J. Newton-Bishop -

S. Puig

 

Genetic susceptibility to melanoma

T. Bishop

 

Familial melanoma

J. Newton-Bishop

 

Genetics and prognosis

E. Nagore

 

Genetics and treatment decision

S. Puig

 

WORKSHOP 1

Prevention & skin cancer screening

Chairs:

A. M. Forsea

V. Del Marmol

 
10:00-10:30 Coffee break - visit to he Exhibition & e-posters viewing
10:30-11:30

INDUSTRY SATELLITE SYMPOSIUM  

BRISTOL-MYERS SQUIBB

     
11:30-11:45

Report of BREAKOUT SESSIONS 1-2

Chairs: J. Malvehy  - U. Leiter-Stöppke -

J. Thompson

     
11:45-12:30

PLENARY LECTURES I

Chairs :

F. M. Camacho - G. Pellacani

 

Total body mapping, non-invasive diagnosis and AI systems in skin cancer detection

A. Halpern

 

How does UV induce skin cancer?

A. Viros
 

     
12:45-13:45 INDUSTRY SATELLITE SYMPOSIUM LUNCH      
14:00-15:00  

SYMPOSIUM 6

Surgery and Neoadjuvancy therapy of melanoma

Chairs: R. Kaufman  - D. Moreno - 

V. Sondak

 

Standards and exceptions in surgery of primary melanomas

R. Kaufman

 

Sentinel lymph node biopsy and lymph node dissection. 

Are they still needed?

D. Moreno  

 

European approaches on SNB+/N+ melanoma patients

S. Testori 

 

Current and future role of neoadjuvant therapy

V. Sondak

SYMPOSIUM 7

New imaging diagnostic

Chairs: J. Malvehy - I. Zalaudek

 

 

Whats new in dermoscopy of skin cancer

I. Zalaudek

 

Digital imaging and beyond

J. Malvehy

 

Confocal microscopy and OCT in skin cancer diagnosis

G. Pellacani

 

Electrical impedanciometry in melanoma detection

R. Hofmann- Wellenhof  

 

 

 
15:15-16:15 INDUSTRY SATELLITE SYMPOSIUM -  MSD      
16:15-16:45 Coffee break - visit to he Exhibition & e-posters viewing
16:45:17:45

SYMPOSIUM 8

Adjuvant therapy in melanoma

Chairs: H. Gogas - J. Hassel

 

Adjuvant Treatment of melanoma in the past

P. Mohr

 

Checkpoint Inhibition as adjuvant Treatment in melanoma

H. Gogas

 

BRAF/MEK Inhibition as adjuvant Treatment in melanoma

J. Hassel

 

Adjuvant vaccination strategies and future perspective

U. Sahin

 

SYMPOSIUM 9

Difficult to treat subtypes of melanoma

 

Chairs: P. Arenberger - C. Carrera -

L. Kandolf-Sekulovic

 

Update on treatment of lentigo maligna

C. Carrera

 

Update on treatment of mucosal melanoma

L. Kandolf Sekulovic

 

Management of melanoma in pregnancy

P. Arenberger

 

Management of melanoma in immunosuppressed patients -

C. Lebbé

 

FREE COMMUNICATIONS I:

Chairs: A. Barreiro -

M. Bylaitè-Bucinskiene

18:00-19:00 INDUSTRY SATELLITE SYMPOSIUM - NOVARTIS

 

   
  AUDITORY MEETING ROOM 1 MEETING ROOM 2 MEETING ROOM 3
08:00-09:00

SYMPOSIUM 10

Treatment of advanced BCC & SCC

Chairs: N. Basset - A.Stratigos -

R. Vieira

 

Classification of advanced BCC

J. J. Grob

 

Update in the management of HhI in the treatment of advanced BCC

N. Basset

 

Management of advanced SCC

A. Stratigos

 

Surgical Treatment in advanced tumors Closed

R. Vieira

SYMPOSIUM 11 

Melanoma biology & genetics

Chairs: R. Scolyer - V. Bataille

 

Melanoma genomics

R. Scolyer

 

Imaging and treating pre-metastatic niches in melanoma

M. Soengas

 

The role of UV in elderly melanoma patients

A. Viros

 

Microbiome and melanoma susceptibility

V. Bataille

 

 

BREAKOUT SESSION 3

Data management in melanoma

Chairs: J.E. Gershenwald -

S. Puig

 

 

 

 

 

 

 

 

 

 

BEAKOUT SESSION 4

Equitance & access to treatments in Europe

Chairs: A.M. Forsea - L. Kandolf Sekulovic

 

 

 

 

 

 

 

 

 

 

 

 

09:00-10:00

SYMPOSIUM 12

Management of cutaneous toxicities

Chairs: B. Dréno - C. Lebbé

 

BRAF +MEK (combination) inhibitors

C. Dessinioti

 

Immune check point inhibitor

B. Dréno

 

Hedgehog inhibitor

I. Zalaudek

 

Anti EGF

C. Lebbé

 

 

 

 

SYMPOSIUM 13

Targeted therapy

Chairs: A. Arance - G. Long - D. Schadendorf

 

Issues in targeted therapy in BRAF mutant melanoma: Adjuvant therapy and which BRAF/MEK combination in the metastatic setting?

G. Long

 

NRAS mutant melanoma: Targeted therapy, are we there yet?

D. Schadendorf

 

Other targets in Melanoma

R. Dummer

 

Targets in non-cutaneous melanoma

A. Arance

BREAKOUT SESSION 5

Running skin cancer centre

Chairs: R.Scolyer - L. Thomas

 

 

 

 

 

 

 

 

 

 

 

 

FREE

COMMUNICATIONS II

Chairs: C. Harwood - J. Oláh - A. Toll

10:00-10:30 Coffee break - visit to the Exhibition & e-posters viewing
10:30-11:30 INDUSTRY SATELLITE SYMPOSIUM - AMGEN      
11:30-11:45

Report of BREAKOUT SESSIONS 3-5

Chairs: J.E. Gershenwald -

L. Kandolf-Sekulovic -

L. Thomas

 

 

   
11:45-12:30

PLENARY  LECTURES II

Chairs: S. Puig - C. Robert

 

How to combine target and immunotherapy?

G. Long

 

Which adjuvant therapy for which patients?

A. Haushild

     
12:45-13:45

INDUSTRY SATELLITE SYMPOSIUM LUNCH 

PIERRE FABRE ONCOLOGY

     
14:00-15:00  

SYMPOSIUM 14

Local therapies in melanoma
Chairs: R. Andtbacka - B. Weide

 

Mechanisms of action of intralesional therapies

Speaker to be confirmed

 

IL-2 and mRNA as intralesional approaches

B. Weide

 

Intralesional combination therapies

Speaker to be confirmed

 

Intralesional therapies - modifiers of the tumor microenvironment

R. Andtbacka 

 

SYMPOSIUM 15

Combination therapies
Chairs: J. Larkin - C. Robert

 

Who should we treat with combo ipi + nivo in the clinic?

J. Larkin

 

ICPI + Targeted therapy combinations: we can but should we?

C. Robert

 

Emerging ICPI combos: clinical prospects: e.g. anti-PD1 + IDO, anti-PD1 +TVEC etc

C. Lebbé

 

The future: moving away from empirical and towards rational combinations

A. Ribas

SYMPOSIUM 16

Brain mets
Chairs: B. Dreno - T.K. Eigentler

F. Meier

 

Monoclonal antibodies in brain metastases

B. Dréno

 

Targeted therapy in brain metastases

T. K. Eigentler

 

Radiation plus targeted/immune therapy: what is known from retrospective studies?

F. Meier

 

Upfront radiosurgery followed by targeted or immune therapy-the Aix-Marseille University experience

J.J. Grob

 

 

15:15-16:15 INDUSTRY SATELLITE SYMPOSIUM - INCYTE BIOSCIENCES INTERNATIONAL      
16:15-16:45 Coffee break - visit to the Exhibition & e-posters viewing
16:45-17:45

SYMPOSIUM 17

Immunotherapy of advanced melanoma

Chairs: C. Blank - R. Dummer

C. Robert

 

Neo-adjuvant therapy for early stage melanoma

C. Blank

 

Precision immunotherapy: dream or reality

R. Dummer

 

Involvement of protein translation control in response to Immunotherapy

C. Robert

 

Rare AE during IT-

L. Heinzerling

SYMPOSIUM 18

Predictive biomarkers

Chairs: C. Höller - O. Michielin

 

Speakers: C. Höller - O. Michielin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SURGICAL WORKSHOP 2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FREE COMMUNICATIONS III

Chairs: A. Arance - A. Boada

17:45-18:15

PARALLEL SATELLITE SYMPOSIUM 3

PARALLEL SATELLITE

SYMPOSIUM 4

 

 

 

AUDITORY

MEETING ROOM 1 MEETING ROOM 2 MEETING ROOM 3
08:30-09:15

SYMPOSIUM 19
Lymphoma
Chairs: T. Estrach - E. Guenova - R. Stadler

 

How to recognise and treat early mycosis fungoides

E. Guenova

 

Targeted Therapies in cutaneous lymphomas

R. Stadler

 

Large scale collaborative data-base driven clinical research in CTCL and PROCLIPI update

J. Scarisbrick

     
09:15-10:00

SYMPOSIUM 20 
Rare malignant skin tumors

Chairs: J. Olàh - P. Saig

 

Other rare cutaneous neoplasms

J. Oláh

 

Dermatofibrosarcoma

P. Saiag

 

Merkel/Kaposi sarcoma

C. Lebbé 

     
10:00-10:30 Coffee Break      
10:30-11:30 INDUSTRY SATELLITE SYMPOSIUM 6      
11:30-12:15

PLENARY LECTURES III

Chairs: C. Garbe - D. Whitaker

 

Skin cancer in non developed countries

D. Whitaker

 

The future of immunotherapy

C. Robert

     
12:15-12:30 CLOSING CEREMONY AND AWARDS      

Secretary

SBC servicios básicos de congresos
Mont-Roig, 13 Atc 2a
08006 Barcelona
Tel. +34 933685538
Fax +34 933685829
www.sbc-congresos.com
info@sbc-congresos.com